FI90419C - Menetelmä 1- 2-/5-dimetyyliaminometyyli-2-(furyylimetyylitio)etyyli/ amino-1-metyyliamino-2-nitroeteenin ja sen hydrokloridin valmistamiseksi - Google Patents
Menetelmä 1- 2-/5-dimetyyliaminometyyli-2-(furyylimetyylitio)etyyli/ amino-1-metyyliamino-2-nitroeteenin ja sen hydrokloridin valmistamiseksi Download PDFInfo
- Publication number
- FI90419C FI90419C FI860123A FI860123A FI90419C FI 90419 C FI90419 C FI 90419C FI 860123 A FI860123 A FI 860123A FI 860123 A FI860123 A FI 860123A FI 90419 C FI90419 C FI 90419C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- ethyl
- hydrochloride
- dimethylaminomethyl
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 36
- 238000002360 preparation method Methods 0.000 title claims description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title description 32
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 30
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 4
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910001923 silver oxide Inorganic materials 0.000 claims description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000008012 organic excipient Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 40
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 229910001961 silver nitrate Inorganic materials 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229910052709 silver Inorganic materials 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 239000004332 silver Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VMXUWOKSQNHOCA-UKTHLTGXSA-N ranitidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-UKTHLTGXSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- -1 nitroketene imine Chemical class 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000007259 addition reaction Methods 0.000 description 4
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 229960000620 ranitidine Drugs 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000002516 radical scavenger Substances 0.000 description 3
- ILRSPKULGBJLBZ-UHFFFAOYSA-N 2-nitroethenimine Chemical compound [O-][N+](=O)C=C=N ILRSPKULGBJLBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical group Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229960001520 ranitidine hydrochloride Drugs 0.000 description 2
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- ZUKSLMGYYPZZJD-UHFFFAOYSA-N ethenimine Chemical compound C=C=N ZUKSLMGYYPZZJD-UHFFFAOYSA-N 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- SVIDAEJFBAYABG-UHFFFAOYSA-N n-methyl-2-nitroethenamine Chemical group CNC=C[N+]([O-])=O SVIDAEJFBAYABG-UHFFFAOYSA-N 0.000 description 1
- RPMXALUWKZHYOV-UHFFFAOYSA-N nitroethene Chemical group [O-][N+](=O)C=C RPMXALUWKZHYOV-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000005188 oxoalkyl group Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000004055 thiomethyl group Chemical group [H]SC([H])([H])* 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU85104A HU196979B (en) | 1985-01-11 | 1985-01-11 | Process for producing basic thioether and salt |
| HU10485 | 1985-01-11 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI860123A0 FI860123A0 (fi) | 1986-01-10 |
| FI860123A7 FI860123A7 (fi) | 1986-07-12 |
| FI90419B FI90419B (fi) | 1993-10-29 |
| FI90419C true FI90419C (fi) | 1994-02-10 |
Family
ID=10947932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI860123A FI90419C (fi) | 1985-01-11 | 1986-01-10 | Menetelmä 1- 2-/5-dimetyyliaminometyyli-2-(furyylimetyylitio)etyyli/ amino-1-metyyliamino-2-nitroeteenin ja sen hydrokloridin valmistamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| KR (1) | KR920010926B1 (cs) |
| CN (1) | CN1005630B (cs) |
| AR (1) | AR242200A1 (cs) |
| AT (1) | AT391470B (cs) |
| CA (1) | CA1262913A (cs) |
| CS (1) | CS261232B2 (cs) |
| DK (1) | DK10486A (cs) |
| ES (1) | ES8703864A1 (cs) |
| FI (1) | FI90419C (cs) |
| GB (1) | GB2169600B (cs) |
| GR (1) | GR860058B (cs) |
| HU (1) | HU196979B (cs) |
| IT (1) | IT1203727B (cs) |
| NO (1) | NO170542C (cs) |
| PT (1) | PT81824B (cs) |
| SU (1) | SU1419519A3 (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU210849B (en) * | 1990-11-09 | 1995-08-28 | Richter Gedeon Vegyeszet | Process for preparing furil derivatives |
| HU207308B (en) * | 1990-11-09 | 1993-03-29 | Richter Gedeon Vegyeszet | Process for producing 1- /2-/5-/dimethyl-amino-methyl/-2-/furyl-methyl-thio/-ethyl//- -amino-1-/methyl-amino-2-nitro-ethylene |
| CN1048984C (zh) * | 1991-12-20 | 2000-02-02 | 多坎化学有限公司 | 晶形1呋喃硝胺氢氯化物的制备 |
| CN102010388B (zh) * | 2009-09-04 | 2012-09-05 | 江苏汉斯通药业有限公司 | 雷尼替丁的制备方法 |
| CN102010389B (zh) * | 2009-09-04 | 2012-11-14 | 江苏汉斯通药业有限公司 | 一种制备盐酸雷尼替丁的方法 |
| CN110590717B (zh) * | 2019-09-18 | 2022-08-26 | 上海大学 | 多取代烯酮亚胺及其合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4233302A (en) * | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
| GB2014561B (en) * | 1977-12-23 | 1982-11-03 | Glaxo Group Ltd | Amine derivatives their preparation and pharmaceutical compositions containing them |
| US4203909A (en) * | 1978-09-26 | 1980-05-20 | Bristol-Myers Company | Furan compounds |
| ES8205211A1 (es) * | 1980-12-05 | 1981-10-16 | Liade Sa Lab | Procedimiento de obtencion de un derivado de amina primaria heterociclica |
| EP0057981A3 (en) * | 1981-02-09 | 1982-08-25 | Beecham Group Plc | Aromatic compounds, processes for their preparation and their use |
| ES8300326A1 (es) * | 1981-05-02 | 1982-11-01 | Especialidades Farmaco Terape | Procedimiento para la obtencion de un compuesto derivado delaminometilfurano |
| ES8206506A1 (es) * | 1981-11-16 | 1982-08-16 | Pharmedical Sa Lab | Procedimiento de preparacion de amino alcosi furanos o tio- fenos. |
| PT76557B (en) * | 1982-04-16 | 1986-01-21 | Inke Sa | Process for preparing furan derivatives and addition salts thereof and of pharmaceutical compositions containing the same |
-
1985
- 1985-01-11 HU HU85104A patent/HU196979B/hu not_active IP Right Cessation
-
1986
- 1986-01-10 CN CN86100111.7A patent/CN1005630B/zh not_active Expired
- 1986-01-10 PT PT81824A patent/PT81824B/pt not_active IP Right Cessation
- 1986-01-10 GB GB08600530A patent/GB2169600B/en not_active Expired
- 1986-01-10 NO NO860071A patent/NO170542C/no unknown
- 1986-01-10 ES ES550809A patent/ES8703864A1/es not_active Expired
- 1986-01-10 AT AT0003486A patent/AT391470B/de not_active IP Right Cessation
- 1986-01-10 AR AR86302826A patent/AR242200A1/es active
- 1986-01-10 FI FI860123A patent/FI90419C/fi not_active IP Right Cessation
- 1986-01-10 CS CS86230A patent/CS261232B2/cs unknown
- 1986-01-10 IT IT47517/86A patent/IT1203727B/it active
- 1986-01-10 GR GR860058A patent/GR860058B/el unknown
- 1986-01-10 SU SU864009783A patent/SU1419519A3/ru active
- 1986-01-10 DK DK10486A patent/DK10486A/da not_active Application Discontinuation
- 1986-01-10 CA CA000499391A patent/CA1262913A/en not_active Expired
- 1986-01-10 KR KR1019860000116A patent/KR920010926B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CS261232B2 (en) | 1989-01-12 |
| DK10486A (da) | 1986-07-12 |
| IT1203727B (it) | 1989-02-23 |
| CN1005630B (zh) | 1989-11-01 |
| ES8703864A1 (es) | 1987-03-01 |
| PT81824B (pt) | 1987-11-30 |
| GR860058B (en) | 1986-05-13 |
| AR242200A1 (es) | 1993-03-31 |
| HUT38922A (en) | 1986-07-28 |
| KR860005802A (ko) | 1986-08-13 |
| NO860071L (no) | 1986-07-14 |
| FI860123A7 (fi) | 1986-07-12 |
| PT81824A (en) | 1986-02-01 |
| GB2169600B (en) | 1988-04-20 |
| ATA3486A (de) | 1990-04-15 |
| HU196979B (en) | 1989-02-28 |
| IT8647517A0 (it) | 1986-01-10 |
| GB8600530D0 (en) | 1986-02-19 |
| NO170542C (no) | 1992-10-28 |
| SU1419519A3 (ru) | 1988-08-23 |
| CA1262913A (en) | 1989-11-14 |
| DK10486D0 (da) | 1986-01-10 |
| FI860123A0 (fi) | 1986-01-10 |
| FI90419B (fi) | 1993-10-29 |
| GB2169600A (en) | 1986-07-16 |
| CN86100111A (zh) | 1986-11-26 |
| ES550809A0 (es) | 1987-03-01 |
| KR920010926B1 (ko) | 1992-12-24 |
| NO170542B (no) | 1992-07-20 |
| AT391470B (de) | 1990-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU180045B (en) | Process for producing new amino-thiasole derivatives | |
| EP3841093A1 (en) | Succinate and fumarate acid addition salts of piperazine derivatives useful as glycosidase inhibitors | |
| FI78297B (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara teofyllinderivat. | |
| IE59713B1 (en) | Amino-thiazole and oxazole derivatives | |
| EA019521B1 (ru) | Способ получения производных пиперазина | |
| US5543414A (en) | Achiral amino acid acyl esters of ganciclovir and its derivatives | |
| FI90419C (fi) | Menetelmä 1- 2-/5-dimetyyliaminometyyli-2-(furyylimetyylitio)etyyli/ amino-1-metyyliamino-2-nitroeteenin ja sen hydrokloridin valmistamiseksi | |
| US4032559A (en) | N,2-dicyanoacetimidates | |
| US5959112A (en) | Process for the preparation of ropivacaine hydrochloride monohydrate | |
| FI79301B (fi) | Foerfarande foer framstaellning av 4-metyl-5- alkyltiometylimidazoler. | |
| FR2840900A1 (fr) | Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments | |
| FI63753C (fi) | Foerfarande foer framstaellning av kristallint simetidin. | |
| KR890002427B1 (ko) | 니자티딘의 제조방법 | |
| CY1463A (en) | A new crystal modification of cimetidine and process for preparing and using same | |
| GB2230526A (en) | Preparation of substituted ethenes | |
| GB2067991A (en) | Process for the Preparation of a Furan Derivative | |
| CS250240B2 (en) | Method of ethandiimidamide's derivatives production | |
| GB2036723A (en) | Mercaptoacylpiperazine carboxylic acid compounds | |
| EP0320532A1 (en) | Novel optically active carboxylic acid derivative l-lysine salt and process for production thereof | |
| KR910007966B1 (ko) | 염기성 티오에테르 및 그의 염의 제조방법 | |
| RU2204556C2 (ru) | Способ получения 1-(парахлорбензгидрил)-4-(2-оксиэтил)пиперазина | |
| JPS62126163A (ja) | 新規な光学活性アルキルチオニンスルホキシイミン及びその製造法 | |
| RU2042671C1 (ru) | Производное дикетен-имина в качестве промежуточного продукта для синтеза ранитидина и способ его получения | |
| KR910001440B1 (ko) | 2-(N-벤질-N-메틸아미노)에틸메틸 2,6-디메틸-4-(m-니트로페닐)-1,4-디히드로피리딘-3,5-디카르복실레이트 및 그의 염산염의 제조방법 | |
| FI84059B (fi) | Foerfarande foer framstaellning av n-/2-//5-/(dimetylamino)metyl/-2-furanylmetyl/tio/etyl/-n'-metyl-2- nitro-1,1-etendiamin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: RICHTER GEDEON VEGYESZETI GYAR R.T. |